F. A. Beidh

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis

G. Perkins, D. Brealey, A. Gordon, 2018 .